Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity-Reference-Cited by-同舟云学术

Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity

Published:2023-04 Issue:4 Volume:26 Page:106335
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Amano Tomokazu,Yu Hong,Amano Misa,Leyder Erica,Badiola Maria,Ray Priyanka,Kim Jiyoung,Ko Akihiro C.,Achour Achouak,Weng Nan-ping,Kochba Efrat,Levin Yotam,Ko Minoru S.H.^ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference54 articles.

1. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2;Gorbalenya;Nat. Microbiol.,2020

2. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates;Walsh;N. Engl. J. Med.,2020

3. An mRNA vaccine against SARS-CoV-2 — preliminary report;Jackson;N. Engl. J. Med.,2020

4. mRNA vaccines in the COVID-19 pandemic and beyond;Hogan;Annu. Rev. Med.,2021

5. COVID-19 mRNA vaccines: platforms and current developments;Szabó;Mol. Ther.,2022

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity;Molecular Therapy;2024-05

2. Clinical perspective on topical vaccination strategies;Advanced Drug Delivery Reviews;2024-05

3. mRNA vaccine designs for optimal adjuvanticity and delivery;RNA Biology;2024-03-26

4. Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19;Vaccines;2024-03-17

5. Adjuvant Novel Nanocarrier-Based Targeted Therapy for Lung Cancer;Molecules;2024-02-29